It was reported to medtronic minimed that the customer experienced leaks.The customer reported hyperglycemia, diabetic ketoacidosis treated with ems/ambulance/er visit, iv insulin drip (intravenous insulin infusion).Customer reported the following led up to the event: no troubleshooting was identified.The event involved product(s) mmt-332a.Customer reported high bgs for which they were hospitalized/received emergency medical treatment.No product return is required for mmt-332a.
|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.No conclusion can be drawn at this time.We therefore consider this report complete to the best of our knowledge.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|